{"id":"https://openalex.org/W2562992227","doi":"https://doi.org/10.1016/s1525-0016(16)33454-2","title":"646. Development of a Novel Chimeric Antigen Receptor as a Therapy Against Solid Tumors","display_name":"646. Development of a Novel Chimeric Antigen Receptor as a Therapy Against Solid Tumors","publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W2562992227","doi":"https://doi.org/10.1016/s1525-0016(16)33454-2","mag":"2562992227"},"language":"en","primary_location":{"id":"doi:10.1016/s1525-0016(16)33454-2","doi":"https://doi.org/10.1016/s1525-0016(16)33454-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1525-0016(16)33454-2","pdf_url":"http://www.cell.com/article/S1525001616334542/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cell.com/article/S1525001616334542/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044390702","display_name":"John Szarejko","orcid":"https://orcid.org/0009-0004-3964-8354","observed_orcids":["https://orcid.org/0009-0004-3964-8354"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Szarejko","raw_affiliation_strings":["Department of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000369032","display_name":"Thomas M. Yankee","orcid":"https://orcid.org/0000-0002-3907-4838","observed_orcids":["https://orcid.org/0000-0002-3907-4838"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas M. Yankee","raw_affiliation_strings":["Department of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109142599","display_name":"Gary D. Myers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1328594524","display_name":"Children's Mercy Hospital","ror":"https://ror.org/04zfmcq84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328594524"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary D. Myers","raw_affiliation_strings":["Division of Pediatric Hematology/Oncology, Children's Mercy Hospital, Kansas City, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Hematology/Oncology, Children's Mercy Hospital, Kansas City, MO","institution_ids":["https://openalex.org/I1328594524"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16637183,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":null,"first_page":"S256","last_page":"S256"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.9570000171661377},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9319999814033508},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/single-chain-antibody-fragments","display_name":"single-chain antibody fragments","score":0.824999988079071},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.6729999780654907},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.6859999895095825},{"id":"https://openalex.org/keywords/off-target-toxicity","display_name":"off-target toxicity","score":0.5849999785423279},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.9047133922576904},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.5723406672477722},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.5605629682540894},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5447846055030823},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.5250679850578308},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5111919045448303},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4557974934577942},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4502035975456238},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.42027729749679565},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3820174038410187},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.26483824849128723},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.17734745144844055},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1641111671924591}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1525-0016(16)33454-2","doi":"https://doi.org/10.1016/s1525-0016(16)33454-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1525-0016(16)33454-2","pdf_url":"http://www.cell.com/article/S1525001616334542/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/s1525-0016(16)33454-2","doi":"https://doi.org/10.1016/s1525-0016(16)33454-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1525-0016(16)33454-2","pdf_url":"http://www.cell.com/article/S1525001616334542/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7799999713897705,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2562992227.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2946717294","https://openalex.org/W4391136234","https://openalex.org/W2982278315","https://openalex.org/W2338192129","https://openalex.org/W2621249739","https://openalex.org/W2143808603","https://openalex.org/W2576968512","https://openalex.org/W2801249734","https://openalex.org/W2766580870","https://openalex.org/W2295842615"],"abstract_inverted_index":{"The":[0],"use":[1],"of":[2,33,48,51],"chimeric":[3],"antigen":[4],"receptor":[5],"(CAR)":[6],"T":[7,53,57,61,73],"cells":[8,62,74],"as":[9,17],"a":[10],"therapy":[11],"for":[12],"cancer":[13],"is":[14],"gaining":[15],"traction":[16],"they":[18],"potentially":[19],"target":[20,76],"tumors":[21],"with":[22,65],"high":[23],"specificity":[24],"and":[25,45],"minimal":[26],"off-target":[27],"toxicities.":[28],"Current":[29],"CAR":[30,56,69,71],"designs":[31],"consist":[32],"an":[34],"antigen-specific":[35],"single":[36],"chain":[37],"antibody":[38],"fragment":[39],"(scFv)":[40],"fused":[41],"to":[42,75],"the":[43,68],"transmembrane":[44],"signaling":[46],"domains":[47],"receptors":[49],"capable":[50],"activating":[52],"cells.":[54,78],"In":[55],"cell":[58],"therapy,":[59],"patients\u2019":[60],"are":[63],"transduced":[64],"cDNA":[66],"encoding":[67],"allowing":[70],"expressing":[72],"tumor":[77]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2017-01-06T00:00:00"}